schools
UTRGV researchers identify biomarker to improve early ALS diagnosis
By Erika De Los Reyes at MyRGV
· May 28, 2026
· 1 min read
Researchers at the University of Texas Rio Grande Valley School of Medicine have identified a new biomarker that may improve early detection of amyotrophic lateral sclerosis, or ALS, a neurodegenerative disease.
ALS remains among the most difficult neurological conditions to understand and treat ...
Key takeaway ALS remains among the most difficult neurological conditions to understand and treat ...
Why this matters in The Brownsville
The breakthrough by University of Texas Rio Grande Valley School of Medicine researchers in identifying a biomarker for early ALS diagnosis has significant implications for the Rio Grande Valley community. With no specific test currently available to confirm ALS, patients often face lengthy and uncertain diagnostic processes, which can delay treatment and worsen outcomes. The new biomarker, p75 extracellular domain, offers a potential solution by allowing for non-invasive urine testing to detect motor neuron damage. This development could be particularly beneficial in the Valley, where access to specialized medical care can be limited. By enabling earlier diagnosis and more accurate tracking of disease progression, the UTRGV researchers' discovery may improve the quality of life for ALS patients and their families in the region. As the research moves forward, it will be important to see how the new biomarker is integrated into clinical practice and whether it leads to improved health outcomes for Valley residents.
About this story
Original reporting by MyRGV . The Brownsville surfaces reporting from trusted publishers and adds local editorial context so readers can quickly understand what a story means for their community. We attribute every source, link to the original report, and follow a documented editorial standards policy. To understand how stories are selected and reviewed, read our about page .
For the complete original report, visit MyRGV . Have a tip or correction? Contact our newsroom .
Category: schools ·
Published: May 28, 2026 ·
Source: MyRGV ·
Reading time: 1 min
Get more The Brownsville stories like this
Free weekly briefing covering schools and other local news. Curated by our editorial team. No spam.
By subscribing you agree to our privacy policy . Unsubscribe anytime.
Frequently asked about this story
What is this story about? Researchers at the University of Texas Rio Grande Valley School of Medicine have identified a new biomarker that may improve early detection of amyotrophic lateral sclerosis, or ALS, a neurodegenerative disease.
ALS remains among the most difficult neurological conditions to understand and treat ...
When was this published? This article was first published on May 28, 2026 by MyRGV and curated for The Brownsville readers.
Who reported this story? This story was reported by Erika De Los Reyes at MyRGV. To learn more about how The Brownsville selects and reviews stories, see our editorial standards .
Where can I find related coverage? See more schools coverage from The Brownsville, or browse our daily briefing and topic hubs .
← Back to all news
More schools →
Today’s briefing
Subscribe to newsletter